Assessment of the effects of this treatment on the incidence and severity of oral adverse events, sepsis/septic shock, acute graft-versus-host disease (GVHD) after transplantation, and overall outcomes of the primary disease
Latest Information Update: 05 Jul 2021
At a glance
- Drugs Polaprezinc (Primary) ; Polyacrylic acid
- Indications Mucositis; Oral ulcer
- Focus Therapeutic Use
- 05 Jul 2021 New trial record
- 01 Jul 2021 Results published in the International Journal of Oral and Maxillofacial Surgery